PERSISTENT COVID CONDITION

Clinical trials for PERSISTENT COVID CONDITION explained in plain language.

Never miss a new study

Get alerted when new PERSISTENT COVID CONDITION trials appear

Sign up with your email to follow new studies for PERSISTENT COVID CONDITION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Could a cancer drug ease long COVID? new trial aims to find out

Symptom relief Ongoing

This Phase 2 trial tests whether the drug plitidepsin can improve overall health in 90 adults with moderate-to-severe long COVID symptoms. Participants receive either plitidepsin or a placebo intravenously over four 3-day cycles, with a 90-day follow-up. The study is double-blind…

Matched conditions: PERSISTENT COVID CONDITION

Phase: PHASE2 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Symptom relief

Last updated Jul 16, 2026 00:00 UTC

PERSISTENT COVID CONDITION

Get alerted when new PERSISTENT COVID CONDITION trials appear

Could a cancer drug ease long COVID? new trial aims to find out